中文 | English
Return
Total: 1105 , 1/111
Show Home Prev Next End page: GO
Author:(Ying-Peng WANG)

1.Tau protein and Alzheimers disease

Ying PENG ; Xiaoliang WANG

Chinese Pharmacological Bulletin 1986;0(06):-

2.The Current Status and Perspectives of Research on Pharmaceut ical Preparations

Ying WANG ; Zhifen PENG ; Haihui WANG

Herald of Medicine 2001;(1):55-56

3.Clinical analysis of endoscopic sphincterotomy for choledocholithiasis

Lixin WANG ; Ying PENG ; Zhi XU

Chinese Journal of Minimally Invasive Surgery 2001;0(01):-

4.Pharmacological research of natural products in the treatment of Alzheimer’ s disease

Lin LI ; Xiaoliang WANG ; Ying PENG

Chinese Pharmacological Bulletin 2016;(2):149-154,155

5.Relationship among the anxious symptoms, coping styles and personality traits in patients with depression

Ying PENG ; Wenbin GUO ; Guoqiang WANG

Chinese Journal of Tissue Engineering Research 2007;11(30):6106-6108

6.Important Roles of Pharmaceutical Excipients Standards and Guidelines System Construction in Excipients Regulatory Reform in China

Ying WANG ; Peng HAN ; Xianglin ZHANG

China Pharmacist 2016;19(9):1726-1730

7.Overview of cerebrospinal fluid and blood candidate biomarkers in Parkinson disease

Dandan CUI ; Xiaoliang WANG ; Ying PENG

Chinese Journal of Pharmacology and Toxicology 2016;30(12):1254-1263

8.Role of Nrf2 in neurodegenerative diseases and recent progress of its activators.

Chunyang ZHAO ; Xiaoliang WANG ; Ying PENG

Acta Pharmaceutica Sinica 2015;50(4):375-84

9.Three-dimensional finite element analysis of stress in the bending root of maxillary first molar

Hui PENG ; Ying ZHANG ; Hongyan WANG

Chinese Journal of Tissue Engineering Research 2013;(33):5949-5956

10.Exposure Risk Assessment of Dioxin-like Compounds for Chinese General Population

Ying WANG ; Jun JIN ; Hao PENG

Journal of Environment and Health 1992;0(04):-

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1105 , 1/111 Show Home Prev Next End page: GO